Cymabay Therapeutics (CBAY)

$32.48 0.00 (0.00%)
16:00 EDT CBAY Stock Quote Delayed 30 Minutes

Why is CymaBay (CBAY) Stock Up 25% Today?

CymaBay stock is rising higher on Monday as CBAY investors react to a $4.3 billion acquisition deal with Gilead Sciences.

7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio

7 Penny Stocks With the Potential to 10X in 2022

7 Disruptive Biotech Stocks to Buy for 2025

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 2.75B
PE Ratio -101.50
EPS -0.32
Volume (Avg. Vol.)
Day's Range -
52-Week Range $7.26 - $32.49
Dividend & Yield N/A (N/A)